The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.
Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com
Unlock the market timeline & signal feed
New Marketing & PR activity — 617 fresh signals just appeared.
The order this company entered each market — oldest to newest
Directeur général
Regional sales manager
Sign up to see the full signal feed
How Servier's international expansion compares to its competitors
ServierYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 ServierYou | 26 | 1 | +3195% | 645 | 33 |
23 roles opened in the last 90 days. Sales-led and concentrated in Japan.
Bucharest, Bucharest, Romania · yesterday
Regional sales manager
Riyadh, Riyadh, Saudi Arabia · 2w ago
Sales Assistant - KSA
Riyadh, Riyadh, Saudi Arabia · last mo.
Key Account Manager, Oncology - Riyadh
43 technologies detected across the stack.
No campaigns running in this window.
Ended7 mentions in the last 90 days.
Insilico Medicine nominates ISM1354, an AI-driven GIPR antagonist for obesity and metabolic diseases, showing superior pharmacokinetics and safety. The company achieved 10 PCC nominations in 2026 and reported $106M revenue.
AI-powered drug discovery company Insilico Medicine will join HKEX Tech 100 Index on September 14, 2026, following strong H1 2026 results with $106M revenue and first profitable half-year.
AI-powered drug discovery company Insilico Medicine will join HKEX Tech 100 Index on September 14, 2026, following strong H1 2026 results with $106M revenue and first profitable half-year.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Servier's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
